Related Experiment Video

Updated: May 15, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Bone metabolism in 2012: Novel osteoporosis targets

Claes Ohlsson1

  • 1Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Sweden. claes.ohlsson@medic.gu.se

Nature Reviews. Endocrinology
|January 9, 2013
PubMed

Insights

Researchers are exploring new antifracture treatments, including antibody therapies and enzyme inhibitors. Novel osteoporosis targets were also identified in 2012 using advanced research methods for safer, more effective therapies.

Area of Science:

  • Biomedical research
  • Pharmacology
  • Orthopedics

Background:

  • Developing effective and safe antifracture treatments is a key research area.
  • Existing treatments for conditions like osteoporosis require continuous improvement.
  • Targeting specific molecular pathways offers potential for novel therapeutic strategies.

Purpose of the Study:

  • To review recent advancements in antifracture treatment research.
  • To highlight novel osteoporosis targets identified through various methodologies.
  • To discuss the potential of emerging therapeutic approaches.

Main Methods:

  • Review of clinical trials and scientific literature.
  • Identification of novel molecular targets for osteoporosis.
  • Analysis of different methodological approaches in target discovery.

Main Results:

  • Promising clinical trials involving sclerostin antibodies are underway.
  • Inhibition of cathepsin K is being investigated as a therapeutic strategy.
  • Several new osteoporosis targets were identified in 2012.

Conclusions:

  • The field of antifracture treatment is rapidly evolving with new therapeutic targets.
  • Antibody-based therapies and enzyme inhibition show significant promise.
  • Diverse research methodologies are crucial for identifying novel therapeutic strategies.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...